AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries.
Each of our employees brings their own unique ideas, approaches and life experiences to AbbVie. This type of diversity creates an eclectic workplace. Our people have the freedom to challenge ideas, take risks and create novel solutions to better meet patient needs. Discoveries are possible at AbbVie because of the environment we’ve designed, one that fosters creativity and rewards innovation.
Fostering a culture of innovation means more than discovering new medicines. It’s about the way we interact with our world and being a good global citizen. It’s about the way we interact with our colleagues, partners and suppliers to build a better business – and a better global community. It’s a commitment we take seriously and one we instill in our people at all levels.
To ensure we walk the talk, AbbVie is dedicated to building stakeholder engagement, transparency, and a work environment that inspires innovation, trust and collaboration.
Closing share price